(Total Views: 380)
Posted On: 05/16/2020 4:45:40 PM
Post# of 11802
And what is it that shareholders deserve?
Bottom line: DECN will succeed or fail in this space based on GenViro product testing. That’s it. Berman either delivers results or he doesn’t.
Clock is ticking. Let’s see what happens.
Bottom line: DECN will succeed or fail in this space based on GenViro product testing. That’s it. Berman either delivers results or he doesn’t.
Clock is ticking. Let’s see what happens.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)